Novavax (NVAX) PT Raised to $61 at B.Riley/FBR, Following Acquisition Of Praha Vaccines
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.14 +2.26%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
B.Riley/FBR analyst Mayank Mamtani raised the price target on Novavax (NASDAQ: NVAX) to $61.00 (from $53.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Clariant AG (CLN:SW) (CLZNY) PT Raised to CHF13 at JPMorgan
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR389 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
